Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Neurology

Building Your Knowledge: Understanding Benign Schwannoma

At a Glance

A benign schwannoma is a slow-growing, non-cancerous tumor that develops on peripheral nerves. While not life-threatening, it can cause pain or weakness if it presses on nearby nerves. Management usually involves careful monitoring with MRI scans or surgical removal for growing tumors.

Hearing the word “tumor” is naturally frightening, but a diagnosis of a benign schwannoma is fundamentally different from a cancer diagnosis. In medical terms, benign means the growth is not cancerous and does not have the ability to spread (metastasize) to distant parts of your body [1][2]. While these tumors require careful management because of where they grow, they are generally slow-growing and highly treatable [3][4].

The Role of Schwann Cells

To understand a schwannoma, it helps to understand the cells it comes from. Schwann cells are the “support crew” for your peripheral nervous system—the network of nerves that connects your brain and spinal cord to the rest of your body [5].

You can think of a nerve like an electrical wire. For the wire to send signals efficiently without short-circuiting, it needs insulation. Schwann cells provide this insulation by wrapping around the nerve fibers (axons) [6][7]. Beyond acting as insulation, these cells also help maintain the health of the nerve and are essential for repairing nerves if they become injured [8][9]. A schwannoma occurs when these cells begin to multiply uncontrollably, creating a lump or mass on the outside of the nerve [3].

Why Schwannomas Form: The NF2 Gene

In many cases, schwannomas occur “sporadically,” meaning they happen by chance without a clear cause. However, researchers have identified a specific genetic “off switch” that typically fails when these tumors develop.

Every Schwann cell has a gene called NF2. This gene is responsible for producing a protein called merlin [10]. Merlin acts as a tumor suppressor, which means its job is to prevent cells from growing too fast or out of control. When the NF2 gene is mutated or damaged, the cell stops producing functional merlin [11]. Without this “brake” in place, the Schwann cells begin to divide and pile up, eventually forming a schwannoma [10][12].

Growth and Prognosis

The word “benign” does not mean “harmless,” but it does mean “not life-threatening” in the majority of cases.

  • Growth Rate: Most schwannomas are slow-growing and encapsulated, meaning they are contained within a distinct “pouch” or sheath and do not invade the surrounding tissue [1][2].
  • Pressure Effects: Because these tumors grow on nerves, they can eventually press against the nerve they started on or squeeze nearby structures [13]. Depending on the location, this pressure can cause pain, numbness, or weakness in the area the nerve serves [3][14].
  • Long-Term Outlook: The prognosis (expected outcome) for a benign schwannoma is excellent. For many patients, the tumor is found incidentally during a scan for something else and may never cause symptoms [15]. If the tumor does become symptomatic or grows large enough to threaten nerve function, surgical excision (removal) is the gold-standard treatment and usually results in a full recovery [4][16].

Current Management Approaches

Modern guidelines emphasize a personalized approach to managing these tumors:

  1. Observation (“Watch and Wait”): If a tumor is small and not causing symptoms, doctors often recommend periodic MRI scans to monitor its size rather than rushing into surgery [15].
  2. Surgical Removal: Surgery is typically reserved for tumors that are growing, causing significant pain, or interfering with muscle movement or sensation [13][17]. The goal of surgery is to remove the tumor while preserving the underlying nerve [4].
  3. Specialist Consultation: Because these tumors involve delicate nerve structures, management often involves a multidisciplinary team, which may include neurologists, neurosurgeons, or neuro-oncologists [18][19].

Common questions in this guide

Is a benign schwannoma cancerous?
No, a benign schwannoma is not cancer. It is a slow-growing tumor that does not have the ability to spread to distant parts of your body. However, it requires monitoring because it can cause localized symptoms by pressing on nearby nerves as it grows.
What causes a schwannoma to form?
Most schwannomas occur randomly. They form when there is a mutation in the NF2 gene, which normally acts as an 'off switch' to prevent cells from growing too fast. When this gene fails, Schwann cells multiply uncontrollably and pile up into a tumor.
What are the common symptoms of a benign schwannoma?
Because these tumors grow directly on nerves, they can squeeze the nerve or nearby structures as they expand. This pressure can result in pain, numbness, tingling, or muscle weakness in the specific area of the body that the affected nerve serves.
Will I immediately need surgery to remove my schwannoma?
Surgery is not always necessary. If your tumor is small and not causing any symptoms, your doctor will likely recommend a 'watch and wait' approach using periodic MRI scans to monitor its size. Surgery is typically reserved for tumors that are growing rapidly, causing severe pain, or interfering with your muscle movement.
Can surgery for a schwannoma cause permanent nerve damage?
The goal of surgery is to completely remove the tumor while preserving the underlying nerve. However, because the tumor grows on delicate nerve tissue, there are risks involved. Your multidisciplinary team, including a neurosurgeon, will evaluate the exact location to determine the likelihood of preserving full nerve function.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the exact location of my schwannoma, and which specific nerve is it affecting?
  2. 2.Based on my imaging, how large is the tumor, and what is the plan for monitoring its growth rate?
  3. 3.Am I showing any neurological deficits, such as muscle weakness or sensory loss, that require immediate intervention?
  4. 4.Given the tumor's location, what are the specific risks of 'watchful waiting' versus surgical removal?
  5. 5.If surgery is recommended, what is the likelihood of preserving the function of the underlying nerve?
  6. 6.Should I undergo genetic testing for the NF2 gene mutation, even if I don't have a family history of these tumors?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Peripheral Nerve Schwannoma: A Review of Varying Clinical Presentations and Imaging Findings.

    Albert P, Patel J, Badawy K, et al.

    The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons 2017; (56(3)):632-637 doi:10.1053/j.jfas.2016.12.003.

    PMID: 28237565
  2. 2

    A rare occurrence of intramasseteric schwannoma - case report and literature review.

    Wang HK, Gong YL, Wang RX, et al.

    Revue de stomatologie, de chirurgie maxillo-faciale et de chirurgie orale 2016; (117(3)):170-2.

    PMID: 27155941
  3. 3

    A Rare Case of Sural Schwannoma With Involvement of the Medial Sural Cutaneous Nerve: A Case Report and Literature Review.

    Petrova K, Gaydarski L, Panev A, et al.

    Cureus 2024; (16(8)):e66190 doi:10.7759/cureus.66190.

    PMID: 39233934
  4. 4

    Hybrid Benign Peripheral Nerve Sheath Tumors: A Comprehensive Literature Review with Emphasis on Their Clinical, Morphological and Genetic Features.

    Salzano S, Caltabiano R, Zanelli M, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(7)) doi:10.3390/diagnostics15070855.

    PMID: 40218204
  5. 5

    Schwann cells in regeneration and cancer.

    Zhang L, Xie J, Dai W, et al.

    Frontiers in pharmacology 2025; (16()):1506552 doi:10.3389/fphar.2025.1506552.

    PMID: 39981185
  6. 6

    Involvement of the Tyro3 receptor and its intracellular partner Fyn signaling in Schwann cell myelination.

    Miyamoto Y, Torii T, Takada S, et al.

    Molecular biology of the cell 2015; (26(19)):3489-503 doi:10.1091/mbc.E14-05-1020.

    PMID: 26224309
  7. 7

    Axo-glial interdependence in peripheral nerve development.

    Fledrich R, Kungl T, Nave KA, Stassart RM

    Development (Cambridge, England) 2019; (146(21)) doi:10.1242/dev.151704.

    PMID: 31719044
  8. 8

    The repair Schwann cell and its function in regenerating nerves.

    Jessen KR, Mirsky R

    The Journal of physiology 2016; (594(13)):3521-31 doi:10.1113/JP270874.

    PMID: 26864683
  9. 9

    NRG1 type I dependent autoparacrine stimulation of Schwann cells in onion bulbs of peripheral neuropathies.

    Fledrich R, Akkermann D, Schütza V, et al.

    Nature communications 2019; (10(1)):1467 doi:10.1038/s41467-019-09385-6.

    PMID: 30931926
  10. 10

    Pathomechanisms in schwannoma development and progression.

    Helbing DL, Schulz A, Morrison H

    Oncogene 2020; (39(32)):5421-5429 doi:10.1038/s41388-020-1374-5.

    PMID: 32616891
  11. 11

    Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in Childhood.

    Castellanos E, Plana A, Carrato C, et al.

    JAMA dermatology 2018; (154(3)):341-346 doi:10.1001/jamadermatol.2017.5464.

    PMID: 29322178
  12. 12

    The importance of nerve microenvironment for schwannoma development.

    Schulz A, Büttner R, Hagel C, et al.

    Acta neuropathologica 2016; (132(2)):289-307 doi:10.1007/s00401-016-1583-8.

    PMID: 27236462
  13. 13

    The Rare Large Common Peroneal Nerve's Schwannoma-A Case Report and Literature Review.

    Harahap R, Harahap ND

    Case reports in oncological medicine 2024; (2024()):9397436 doi:10.1155/2024/9397436.

    PMID: 39262572
  14. 14

    Giant schwannoma of thoracic vertebra: A case report.

    Zhou Y, Liu CZ, Zhang SY, et al.

    World journal of clinical cases 2021; (9(36)):11448-11456 doi:10.12998/wjcc.v9.i36.11448.

    PMID: 35071577
  15. 15

    Frontal nerve schwannoma in a 16-year-old girl presenting with a rapid growth for 2 years.

    Murofushi K, Tsutsumi S, Tomita S, et al.

    Surgical neurology international 2024; (15()):400 doi:10.25259/SNI_782_2024.

    PMID: 39640354
  16. 16

    Cervical Schwannoma: Diagnosis and Treatment in a Second-Level Hospital in Mexico.

    Galaz Hernández R, Granados Flores AA, Garcia Palazuelos Ramirez JM, et al.

    Cureus 2025; (17(7)):e87481 doi:10.7759/cureus.87481.

    PMID: 40777668
  17. 17

    Resection of a giant intraspinal and extraspinal schwannoma with cystic change using a two-step surgery: a case report.

    Feng X, Huang J, Yu H, et al.

    BMC musculoskeletal disorders 2024; (25(1)):715 doi:10.1186/s12891-024-07821-3.

    PMID: 39237878
  18. 18

    Clinical practice guideline on the management of vestibular schwannoma.

    Lassaletta L, Acle Cervera L, Altuna X, et al.

    Acta otorrinolaringologica espanola 2024; (75(2)):108-128 doi:10.1016/j.otoeng.2023.10.005.

    PMID: 38346489
  19. 19

    A Critical Overview of Targeted Therapies for Vestibular Schwannoma.

    Tamura R, Toda M

    International journal of molecular sciences 2022; (23(10)) doi:10.3390/ijms23105462.

    PMID: 35628268

This page provides general educational information about benign schwannomas and their management. It does not replace professional medical advice. Always consult your neurologist or neurosurgeon regarding your specific symptoms and treatment options.

Get notified when new evidence is published on Benign schwannoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.